biote vs Glass House Brands
BTMD and GLAS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BTMD and GLAS compare
biote grew revenue faster over the last twelve months (−8.6% versus −9.4% for Glass House Brands).
biote keeps more of each dollar of sales as profit, with a net margin of −1.1% compared with −16.3% at Glass House Brands.
Glass House Brands scores higher on the StockData Score (5 against 4 for biote), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BTMD | GLAS |
|---|---|---|
| Size and price | ||
| Market cap | $38.3M | – |
| Share price | $1.06 | $1.27 |
| Change, 1 year | −59.7% | −83.1% |
| Change, 5 years | −89.1% | −72.1% |
| Beta (5Y) | 0.51 | 0.67 |
| Employees | 223 | 472 |
| StockData Score | ||
| Total score | 4 | 5 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× | – |
| EV/EBITDA | 12.2× | – |
| P/FCF | 5.2× | – |
| FCF yield | 19.4% | – |
| Growth | ||
| Revenue growth (TTM) | −8.6% (better) | −9.4% |
| Revenue growth, 5Y average | – | 30.4% |
| Net income growth (TTM) | −107% (better) | −5815% |
| EPS growth (TTM) | −114% | – |
| Profitability | ||
| Gross margin | 67.5% (better) | 42.3% |
| Operating margin | 5.0% (better) | −9.1% |
| Net margin | −1.1% (better) | −16.3% |
| FCF margin | 4.1% (better) | −8.6% |
| Return on equity | – | −31.2% |
| Return on invested capital | 18.5% (better) | −9.9% |
| Financial health | ||
| Debt / equity | – | 0.93 |
| Net debt / EBITDA | 8.62 | – |
| Interest coverage | – | −2.3× |
| Current ratio | 1.37 | 1.78 (better) |
| Altman Z-score | 1.65 | – |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 18.9% | – |
| Shareholder yield | 18.9% | – |
| Ownership | ||
| Held by institutions | 36.6% | 24.9% |
| Held by insiders | 23.3% | 0.04% |
| Insider net buying, 12 months | $202K (better) | −$354K |
| Short interest, % of float | 3.1% | 0.82% |
Go deeper
- BTMD stock overview
- BTMD income statement
- BTMD valuation and score
- GLAS stock overview
- GLAS income statement
- GLAS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.